Synchronized Diaphragmatic Stimulation in Symptomatic Heart Failure

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 270 participants.

Also called NCT06552637

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 270 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06552637
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Georgia (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06552637. Randomized; quadruple masking; primary purpose treatment. Start 2026-07-08 (actual); primary completion 2028-07 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Synchronized Diaphragmatic Stimulation in Symptomatic Heart Failure
Acronym
RECOVER-HF
Intervention (Device)
Synchronized Diaphragmatic Stimulation
Lead sponsor
VisCardia Inc. (class: industry)
Collaborator
Clinical Accelerator (class: industry)
Collaborator
Duke Clinical Research Institute (class: other)

Record details

Record id
cardio:ct-nct06552637
Content hash
966207b380196d5abd9e8ee8dad9625ec7b97f429a7c4138b7e6d348a75bd42d